Merck Manual

Please confirm that you are a health care professional

honeypot link

Measles, Mumps, and Rubella (MMR) Vaccine


Margot L. Savoy

, MD, MPH, Lewis Katz School of Medicine at Temple University

Last full review/revision Jun 2021| Content last modified Dec 2021
Click here for Patient Education

Preparations of MMR Vaccine

The MMR vaccine contains live-attenuated measles and mumps viruses, prepared in chicken embryo cell cultures. It also contains live-attenuated rubella virus, prepared in human diploid lung fibroblasts.

Indications for MMR Vaccine

All adults who were born in 1957 or later should be given 1 dose of the vaccine unless they have one of the following:

  • Documentation of vaccination with one or more doses of MMR

  • Laboratory evidence that indicates immunity to the 3 diseases

  • A contraindication to the vaccine

Documented diagnosis of disease by a physician is not considered acceptable evidence of immunity for measles, mumps, or rubella.

Pearls & Pitfalls

  • Documented diagnosis of disease by a physician is not considered acceptable evidence of immunity for measles, mumps, or rubella.

A 2nd dose of MMR vaccine (or, if they have not been vaccinated, 2 doses given ≥ 28 days apart) is recommended for adults who are likely to be exposed:

  • Students in colleges or other post–high school educational institutions

  • Health care workers born in 1957 or later with no evidence of immunity

  • International travelers

  • Patients with HIV infection and a CD4 cell count ≥ 200/mcL for ≥ 6 months

People born before 1957 are generally considered immune. However, such people who work within health care facilities (whether or not they have patient care duties) should be considered for vaccination if they have no evidence of immunity. Two doses of MMR are given (one dose if only rubella coverage is needed).

If people aged ≥ 12 months were previously given ≤ 2 doses of mumps-containing vaccine and are identified by public health authorities to be at increased risk of mumps during a mumps outbreak, they should be given 1 dose of MMR vaccine.

Because rubella during pregnancy can have dire consequences for the fetus (eg, miscarriage, multiple birth defects), all women of childbearing age, regardless of birth year, should be screened for rubella immunity. If there is no evidence of immunity, women who are not pregnant should be vaccinated. Pregnant women who do not have evidence of immunity should be vaccinated when pregnancy is completed and before they are discharged from the health care facility.

People who were vaccinated with inactivated (killed) measles vaccine or measles vaccine of unknown type during 1963 to 1967 should be revaccinated with 2 doses of MMR vaccine.

People who were vaccinated before 1979 with killed mumps vaccine or mumps vaccine of unknown type and who are at high risk of mumps exposure should be offered revaccination with 2 doses of MMR vaccine.

Contraindications and Precautions of MMR Vaccine

Contraindications for the MMR vaccine include

Women who have been vaccinated should avoid becoming pregnant for ≥ 28 days afterward. The vaccine virus may be capable of infecting a fetus during early pregnancy. The vaccine does not cause congenital rubella syndrome Symptoms and Signs Congenital rubella is a viral infection acquired from the mother during pregnancy. Signs are multiple congenital anomalies that can result in fetal death. Diagnosis is by serology and viral... read more , but risk of fetal damage is estimated at ≤ 3%.

Precautions with the MMR vaccine include

  • Moderate or severe acute illness with or without fever (vaccination is postponed until illness resolves)

  • Recent (within 11 months) treatment with blood products that contain antibody (specific interval depends on the product)

  • History of thrombocytopenia or thrombocytopenic purpura

If a person is infected with Mycobacterium tuberculosis, MMR vaccine and possibly MMRV vaccine may temporarily suppress the response to tuberculin testing. Thus, if needed, this test can be done before or at the same time as vaccination. If people have already been vaccinated, testing should be postponed for 4 to 6 weeks after vaccination.

Dose and Administration of MMR Vaccine

The MMR vaccine dose is 0.5 mL subcutaneous. The MMR vaccine is routinely given to children in 2 doses: one at age 12 to 15 months and one at age 4 to 6 years.

Adverse Effects of MMR Vaccine

More Information

The following are some English-language resources that may be useful. Please note that THE MANUAL is not responsible for the content of these resources.

Drugs Mentioned In This Article

Drug Name Select Trade
No US brand name
No US brand name
No US brand name
Gammagard S/D
No US brand name
No US brand name
No US brand name
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read
Test your knowledge
Tetanus is caused by a toxin produced by Clostridium tetani in contaminated wounds. Patients with burns or surgical wounds are at risk, but tetanus may occur after trivial or even inapparent wounds. Disease incidence has been decreased due to immunizations, but deaths still occur worldwide, with an estimated 200,000 deaths annually. Mortality is highest in which of the following patient populations?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest